Stability and bifurcation analysis of an HIV model with pre-exposure prophylaxis and treatment interventions

被引:7
作者
Chazuka, Zviiteyi [1 ]
Mudimu, Edinah [1 ]
Mathebula, Dephney [1 ]
机构
[1] Univ South Africa, Coll Econ & Management Sci, Dept Decis Sci, Preller St, Pretoria, South Africa
关键词
Backward bifurcation; PrEP adherence; PrEP effectiveness; PrEP efficacy; Sensitivity analysis; Treatment interventions; BACKWARD BIFURCATIONS; TRANSMISSION; PREP; TUBERCULOSIS;
D O I
10.1016/j.sciaf.2023.e01979
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oral pre-exposure prophylaxis (PrEP) is a highly effective method of HIV prevention. However, despite its effectiveness, the use of PrEP is not without challenges. These challenges include issues such as adherence, societal stigma, as well as accessibility and cost. PrEP effectiveness measures the drug's performance in the real world while efficacy measures the degree to which PrEP inhibits HIV infection and its transmission. In this paper, we address the problem of reduced effectiveness of PrEP, primarily due to non-adherence, and the impact on the dynamics of HIV infection. The study aims to determine the critical threshold of PrEP effectiveness required to avoid the occurrence of a backward bifurcation. The conditions for a stable infection -free equilibrium are stated. Through a rigorous analysis of the proposed mathematical model using Castillo-Chavez and Song's bifurcation theorem, it was found that backward bifurcation occurs when PrEP effectiveness falls below 100%. In contrast, if the effectiveness is 100%, which implies full adherence to PrEP, the model undergoes forward bifurcation. The existence of a backward bifurcation bears significant consequences, most notably the co-existence of the infection-free equilibrium and the endemic equilibrium. Under these circumstances, the eradication of HIV within a particular community becomes very difficult. The results of the numerical analysis demonstrate the important role of proper adherence in augmenting the effectiveness of PrEP and, consequently, curbing HIV transmission within communities. Nevertheless, intensive efforts are required to boost adherence to PrEP. Therefore, other HIV control measures need to be promoted to further reduce transmission.
引用
收藏
页数:21
相关论文
共 50 条
  • [31] Drug Resistance During HIV Pre-Exposure Prophylaxis
    Gibas, Kevin M.
    van den Berg, Polly
    Powell, Victoria E.
    Krakower, Douglas S.
    DRUGS, 2019, 79 (06) : 609 - 619
  • [32] Trial size, HIV pre-exposure prophylaxis, and breastfeeding
    Bird, Sheila M.
    LANCET, 2016, 387 (10033) : 2090 - 2091
  • [33] Mathematical assessment of the role of pre-exposure prophylaxis on HIV transmission dynamics
    Simpson, Lindsay
    Gumel, Abba B.
    APPLIED MATHEMATICS AND COMPUTATION, 2017, 293 : 168 - 193
  • [34] Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
    Tan, Darrell H. S.
    Hull, Mark W.
    Yoong, Deborah
    Tremblay, Cecile
    O'Byrne, Patrick
    Thomas, Rejean
    Kille, Julie
    Baril, Jean-Guy
    Cox, Joseph
    Giguere, Pierre
    Harris, Marianne
    Hughes, Christine
    MacPherson, Paul
    O'Donnell, Shannon
    Reimer, Joss
    Singh, Ameeta
    Barrett, Lisa
    Bogoch, Isaac
    Jollimore, Jody
    Lambert, Gilles
    Lebouche, Bertrand
    Metz, Gila
    Rogers, Tim
    Shafran, Stephen
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (47) : E1448 - E1458
  • [35] Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection
    Gengiah, Tanuja N.
    Moosa, Atika
    Naidoo, Anushka
    Mansoor, Leila E.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (01) : 70 - 85
  • [36] Reported Side Effects and Adherence of Daily HIV Pre-Exposure Prophylaxis Users in Ontario, Canada: An Analysis of the Ontario Pre-Exposure Prophylaxis Cohort Study
    Rudd, Monica
    McGarrity, Matthew
    Lisk, Ryan
    MacPherson, Paul
    Knox, David
    Woodward, Kevin
    Reinhart, Jeff
    MacLeod, John
    Bogoch, Isaac I.
    Clatworthy, Deanna
    Biondi, Mia J.
    Sullivan, Sean
    Li, Alan
    Durrant, Garfield
    Schonbe, Andrew
    Ongoiba, Fanta
    Burchell, Ann N.
    Tan, Darrell H. S.
    AIDS PATIENT CARE AND STDS, 2024, 38 (09) : 382 - 392
  • [37] Pre-exposure Prophylaxis in HIV Research: A Latent Dirichlet Allocation Analysis (GAPRESEARCH)
    Tran, Bach X.
    Phan, Hai T.
    Nguyen, Quang N.
    Ewedairo, Olagoke A.
    Vu, Giang T.
    Ha, Giang H.
    Nguyen, Thao P.
    Latkin, Carl A.
    Ho, Cyrus S. H.
    Ho, Roger C. M.
    AIDS REVIEWS, 2020, 22 (02) : 103 - 111
  • [38] Knowledge domain and emerging trends in HIV pre-exposure prophylaxis: A visualization analysis via CiteSpace
    Chen, Xi
    Lai, Yu
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [39] Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care
    Tung, Elyse L.
    Thomas, Annalisa
    Eichner, Allyson
    Shalit, Peter
    SEXUAL HEALTH, 2018, 15 (06) : 556 - 561
  • [40] Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
    Gaspar, Mark
    Salway, Travis
    Grace, Daniel
    SOCIAL THEORY & HEALTH, 2022, 20 (02) : 171 - 187